JP2016033160A5 - - Google Patents

Download PDF

Info

Publication number
JP2016033160A5
JP2016033160A5 JP2015234461A JP2015234461A JP2016033160A5 JP 2016033160 A5 JP2016033160 A5 JP 2016033160A5 JP 2015234461 A JP2015234461 A JP 2015234461A JP 2015234461 A JP2015234461 A JP 2015234461A JP 2016033160 A5 JP2016033160 A5 JP 2016033160A5
Authority
JP
Japan
Prior art keywords
improving
blood cells
hydrogen atom
metal
cancerous anemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015234461A
Other languages
English (en)
Japanese (ja)
Other versions
JP6093428B2 (ja
JP2016033160A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2015234461A priority Critical patent/JP6093428B2/ja
Priority claimed from JP2015234461A external-priority patent/JP6093428B2/ja
Publication of JP2016033160A publication Critical patent/JP2016033160A/ja
Publication of JP2016033160A5 publication Critical patent/JP2016033160A5/ja
Application granted granted Critical
Publication of JP6093428B2 publication Critical patent/JP6093428B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015234461A 2011-10-12 2015-12-01 がん性貧血改善・予防剤 Active JP6093428B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2015234461A JP6093428B2 (ja) 2011-10-12 2015-12-01 がん性貧血改善・予防剤

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2011225383 2011-10-12
JP2011225383 2011-10-12
JP2012081346 2012-03-30
JP2012081346 2012-03-30
JP2015234461A JP6093428B2 (ja) 2011-10-12 2015-12-01 がん性貧血改善・予防剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2013538532A Division JP5881722B2 (ja) 2011-10-12 2012-10-05 がん性貧血改善・予防剤

Publications (3)

Publication Number Publication Date
JP2016033160A JP2016033160A (ja) 2016-03-10
JP2016033160A5 true JP2016033160A5 (https=) 2016-04-21
JP6093428B2 JP6093428B2 (ja) 2017-03-08

Family

ID=48081825

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013538532A Active JP5881722B2 (ja) 2011-10-12 2012-10-05 がん性貧血改善・予防剤
JP2015234461A Active JP6093428B2 (ja) 2011-10-12 2015-12-01 がん性貧血改善・予防剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2013538532A Active JP5881722B2 (ja) 2011-10-12 2012-10-05 がん性貧血改善・予防剤

Country Status (7)

Country Link
US (1) US9539225B2 (https=)
EP (1) EP2767280B1 (https=)
JP (2) JP5881722B2 (https=)
CN (1) CN103974702A (https=)
HK (1) HK1200323A1 (https=)
TW (1) TWI590823B (https=)
WO (1) WO2013054770A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5818906B2 (ja) 2011-10-12 2015-11-18 Sbiファーマ株式会社 抗ガン剤の副作用の予防剤及び/又は治療剤
US20160271090A1 (en) * 2013-10-29 2016-09-22 Tokyo University Of Agriculture Frataxin enhancer
EP3508200B1 (en) 2016-09-02 2024-04-10 SBI Pharmaceuticals Co., Ltd. Aqueous formulation containing 5-aminolevulinic acid or the like
JP2024006280A (ja) 2022-07-01 2024-01-17 ネオファーマジャパン株式会社 安定性に優れた非水性製剤
CN116036232A (zh) * 2023-02-09 2023-05-02 山东深海生物科技股份有限公司 一种含5-氨基乙酰丙酸或其衍生物的安神助眠药剂及制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4754731B2 (ja) 2001-07-31 2011-08-24 コスモ石油株式会社 豚成育促進剤及び豚成育促進方法
JP5295652B2 (ja) * 2008-06-16 2013-09-18 Sbiファーマ株式会社 光障害の軽減剤
EP2340821B1 (en) 2008-10-27 2017-01-25 SBI Pharmaceuticals Co., Ltd. Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient
JP5611548B2 (ja) 2009-07-08 2014-10-22 Sbiファーマ株式会社 5−アミノレブリン酸若しくはその誘導体、又はそれらの塩を有効成分とするがんの予防・改善剤
US9394324B2 (en) 2010-03-23 2016-07-19 Vifor (International) Ag Fe(III) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias
US9018257B2 (en) * 2011-03-24 2015-04-28 Bar Ilan University 5-aminolevulinic acid derivatives, methods for their preparation and uses thereof
EP2767276B1 (en) * 2011-10-12 2018-10-03 SBI Pharmaceuticals Co., Ltd. Improving / prophylactic agent for chronic kidney disease

Similar Documents

Publication Publication Date Title
JP2016033160A5 (https=)
Crowley et al. A one pot multi-component CuAAC “click” approach to bidentate and tridentate pyridyl-1, 2, 3-triazole ligands: Synthesis, X-ray structures and copper (II) and silver (I) complexes
JP2016500082A5 (https=)
JP2013522292A5 (https=)
JP2012087321A5 (https=)
JP2018516888A5 (https=)
JP2019527728A5 (https=)
JP2013102146A5 (ja) 化合物
EP4329431A3 (en) Novel heteroleptic iridium complexes
JP2017525730A5 (https=)
RU2014115847A (ru) Пирролопиримидиновые соединения для лечения злокачественной опухоли
JP2015524406A5 (https=)
JP2015524457A5 (https=)
JP2016505595A5 (https=)
JP2015517574A5 (https=)
JP2013216975A5 (https=)
JP2008528671A5 (https=)
JP2012532136A5 (https=)
EA201300259A1 (ru) Хелатные комплексы олигонуклеотидов
MX388849B (es) Derivados de heteroarilpiperidina y de heteroarilpiperazina como fungicidas.
JP2015530408A5 (https=)
JP2016074674A5 (https=)
JP2019534865A5 (https=)
JP2015528814A5 (https=)
JP2013502441A5 (https=)